Skip to main content

J1459 HCPCS Level II Code: Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg

Medicare Coverage & Payment

  • CMS short descriptor: Inj ivig privigen 500 mg
  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: January 1, 2009

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Code Overview

Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg is a HCPCS Level II code (J1459). CMS assigns coverage code C — Carrier judgment. Short description: Inj ivig privigen 500 mg.

Summary composed by MedCoder from this code's official HCPCS Level II record. The tabular instructional notes themselves appear verbatim below.

Change history

  • 2009-01-01
    Added to the code set
    Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $51.22

44206-0436-05 — Privigen — CSL Behring L.L.C. (size 50 × qty 1 (500 MG per billing unit))

44206-0437-10 — Privigen — CSL Behring L.L.C. (size 110 × qty 1 (500 MG per billing unit))

44206-0438-20 — Privigen — CSL Behring L.L.C. (size 200 × qty 1 (500 MG per billing unit))

44206-0439-40 — Privigen — CSL Behring L.L.C. (size 400 × qty 1 (500 MG per billing unit))

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J1459 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (35)

  • J1410 — Injection, estrogen conjugated, per 25 mg [Sibling]
  • J1411 — Injection, etranacogene dezaparvovec-drlb, per therapeutic dose [Sibling]
  • J1412 — Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes [Sibling]
  • J1413 — Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose [Sibling]
  • J1414 — Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose [Sibling]
  • J1426 — Injection, casimersen, 10 mg [Sibling]
  • J1427 — Injection, viltolarsen, 10 mg [Sibling]
  • J1428 — Injection, eteplirsen, 10 mg [Sibling]
  • and 27 more

Change history

  • 2009-01-01 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J1459 in its code family, with their registry titles.

  • J1450 — Injection fluconazole, 200 mg
  • J1451 — Injection, fomepizole, 15 mg
  • J1452 — Injection, fomivirsen sodium, intraocular, 1.65 mg
  • J1453 — Injection, fosaprepitant, 1 mg
  • J1454 — Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
  • J1455 — Injection, foscarnet sodium, per 1000 mg
  • J1456 — Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
  • J1457 — Injection, gallium nitrate, 1 mg
  • J1458 — Injection, galsulfase, 1 mg
  • J1460 — Injection, gamma globulin, intramuscular, 1 cc